期刊文献+

12例多种羧化酶缺乏症的基因突变分析 被引量:10

Gene mutation analyses in Chinese children with multiple carboxylase deficiency
原文传递
导出
摘要 目的旨在从基因水平证实多种羧化酶缺乏症(multiplecarboxylasedeficiency,MCD)的诊断,探讨我国MCD患儿的基因突变情况。方法12例MCD患儿接受基因诊断。采用PCR及直接测序法分别对4例生物素酶(biotinidase,BT)缺乏症和8例全羧化酶合成酶(holocarboxylasesynthetas,HLCS)缺乏症进行BT基因和HLCS基因突变分析,对基因新突变通过限制性片段长度多态性分析及患儿父母和50名正常对照者基因检测以证实。结果12例患儿基因突变检出率100%。4例BT缺乏症中发现BT基因突变6种:C.98104del7ins3,C.1369G〉A(V457M),C.1157G〉A(W386X),C.1284C〉A(Y428X),C.1384delA,c-493—1494insT,后4种为新突变。8例HLCS缺乏症中发现HLCS基因突变4种:c.126G〉T(E42D),c.1994G〉C(R665P),c.1088T〉A(V363D),c.1522C〉T(RS08W),后两种为热点突变[75%(12/16)],c.1994G〉C为新突变。结论本研究从基因水平上证实了12例MCD的诊断。共发现了6种BT基因突变,4种HLCS基因突变,其中5种为新突变;得出2种HLCS基因的热点突变。 Objective To confirm the diagnosis of multiple carboxylase deficiency (MCD) on the gene level and explore the mutations in Chinese children with MCD. Methods Biotinidase (BT) and holocarboxylase synthetase (HLCS) genes were analyzed by PCR and direct sequencing for the 4 BT deficiency patients and 8 HLCS deficiency patients, respectively. The identified mutations in the parents of the patients and 50 normal controls were screened by PCR restriction fragment length polymorphism and direct DNA sequencing. Results Total detection rate of gene mutation is 100% in the 12 children with MCD. Six mutations were detected in the 4 children with BT deficiency, they were c. 98-104de17ins3, c. 1369G〉A (V457M), c. 1157G〉A(W386X), c. 1284C〉A(Y428X), c. 1384delA and c. 1493_1494insT. The last four were novel mutations. Four mutations were found in the 8 children with HLCS deficiency. They were c. 126G〉T (E42D),e. 1994G〉C (R665P), c. 1088T〉A (V363D and c. 1522C〉T (R508W). The last two were "hot spot" mutations [ 75 % ( 12/16 ) ], and c. 1994G〉 C ( R665 P) was a novel mutation. Conclusion This study confirmed the diagnosis of 12 patients with MCD on the gene level. Six mutations were found in the BT gene and 4 in the HLCS gene, including 5 novel mutations. Two mutations of the HLCS gene are probably "hot spot" mutations in Chinese children with HLCS deficiency.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2009年第5期504-510,共7页 Chinese Journal of Medical Genetics
基金 基金项目:国家高技术研究发展计划(863计划)(2007AA022447) “十一五”国家科技支撑计划支撑项目(2006BA105A05,2006BA105A07) 上海交通大学医学院科技基金(06xJ21024)
关键词 生物素酶 全羧化酶合成酶 串联质谱 突变 多种羧化酶缺乏症 biotinidase holocarboxylase tandem mass spectrometry mutation multiple carboxylase deficiency
  • 相关文献

参考文献17

  • 1Neto EC,Schulte J,Rubim R,et al.Newborn screening for biotinidased efficiency in Brazil:biochemical and molecular characterizations.Braz J Med Biol Res,2004,37:295-299.
  • 2Suzuki Y,Yang X,Aoki Y,et al.Mutations in the holocarboxylase synthetase gene HLCS.Hum Mutat,2005,26:285-290.
  • 3Han LS,Ye J,Qiu WJ,et al.Selective screening for inborn errors of metabolism on clinical patients using tandem mass spectrometry in China:a four-year report.J Inherit Metab Dis,2007,30:507-514.
  • 4李端,刘丽,李秀珍,程静,赵小媛,周荣.中国人多种羧化酶缺陷症患儿4例及其父母基因突变分析[J].中华儿科杂志,2006,44(11):865-868. 被引量:6
  • 5Wolf B,Jensen KP,Barshop B,et al.Biotinidase deficiency:novel mutations and their biochemical and clinical correlates.Hum Mutat,2005,25:413.
  • 6Wolf B,Hsia YE,Sweetman L,et al.Multiple carboxylase deficiency:clinical and biochemical improvement following neonatal biotin treatment.Pediatrics,1981,68:113-118.
  • 7Cole H,Reynolds TR,Lockyer JM,et al.Human serum biotinidase:cDNA cloning,sequence and characterization.J Biol Chem,269:6566-6570.
  • 8Suzuki Y,Aoki Y,Ishida Y,et al.Isolation and characterization of mutations in the human holocarboxylase synthetase cDNA.Nat Genet,1994,8:122-128.
  • 9Knight HC,Reynolds TR,Meyers GA,et al.Structure of the human biotinidase gent.Mamrn Genome,1998,9:327-330.
  • 10Yang X,Aoki Y,Li X,et al.Structure of human holocarboxylase synthetase gene and mutation spectrum of holocarboxylase synthetase deficiency.Hum Genet,2001,109:526-534.

二级参考文献18

  • 1Wolf B, Heard GS, Weissbecker KA, et al. Biotinidase deficiency:initial clinical features and rapid diagnosis. Ann Neurol, 1985, 18:614-617.
  • 2Wolf B,Heard GS,Jefferson LG,et a1.Clinical findings in four children with biotinidase deficiency detected through a statewide neonatal screening program.N Engl J Med,1985,313:16-19.
  • 3Suormala T, Wick H, Bonjour JP, et al. Intestinal absorption and renal excretion of biotin in patients with biotirddase deficiency. Eur J Pediatr, 1985, 144: 21-26.
  • 4Wastell HJ, Bartlett K, Dale G, et al. Biotinidese deficiency: a survey of 10 cases. Arch Dis Child, 1988, 63: 1244-1249.
  • 5Suormala TM, Baumgartner ER, Wick H, et al. Comparison of patients with complete and partial biotinidaso deficiency: biochemical studies. J Inherit Metab Dis, 1990, 13: 76-92.
  • 6Pomponio RJ, Hymes J, Reynolds TR, et al. Mutations in the human biotinidase gene that cause profound biotlnldase deficiency in symptomatic children : molecular, biochemical, and clinical analysis. Pediatr Res, 1997 42: 840-848.
  • 7Multi A, Moslinger D, Item CB, et al. Molecular characterization of 34 patients with biotinidase deficiency ascertained by newborn screening and family investigation. Eur J Hum Genet, 2001, 9:237-243.
  • 8罗小平.有机酸代谢障碍[A].左启华.小儿神经系统疾病:第2版[C].北京:人民卫生出版社,2002.472-500.
  • 9Wolf B,Heard GS.Screening for biotinidase deficiency in newborns:worldwide experience.Pediatrics,1990,85:512-517.
  • 10Aoki Y,Suzuki Y,Sakamoto O,et al.Molecular analysis of holocarboxylase synthetase deficiency:a missense mutation and a single base deletion are predominant in Japanese patients.Biochim Biophys Acta,1995,1272:168-174.

共引文献24

同被引文献94

引证文献10

二级引证文献83

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部